Company profile
Reflect Scientific, Inc.
OTC: RSCF · Healthcare · Medical - Instruments & Supplies
#865 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ 54GM —SS 45
v0.1 · 25/100 weight · pillars only
↑ disclosure history, listing tenure · ↓ revenue growth (YoY), workforce scale
Methodology →Revenue TTM
$1.6M
Rev growth YoY (TTM)
-9.8%
Net income (FY)
-$459.0k
Employees
6
as of 2026-08-24
Market cap
$4.3M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.1M$1.1M2023
Net income-$459.0k-$459.0k2023
Operating income-$467.3k-$467.3k2023
Total assets$2.7M$2.7M2023
Liabilities$776.3k$776.3k2023
Equity$1.9M$1.9M2023
Revenue trend
FY2016 – FY2023 · USD
FY16
FY17
FY18
FY19
FY21
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Reflect Scientific, Inc.’s revenue?
Reflect Scientific, Inc. booked $1.1M in FY2023 revenue, contracting 47% year over year — slower than 81% of Healthcare companies we track, at a -42.5% net margin.
Peers · Healthcare
Kaleido Biosciences, Inc.——White River Energy Corp.——Matinas BioPharma Holdings, Inc.32DFirst Choice Healthcare Solutions, Inc.26DOrgenesis Inc.——Marijuana Company of America, Inc.——Neighbors
Utah →Key facts
CEOKim Boyce
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersOrem, UT
ExchangeOTC: RSCF
Employees6
IPO date2007-05-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.